Melatonin in type 2 diabetes
Phase 3
Recruiting
- Conditions
- diabetes.Type 2 diabetes mellitus without complications
- Registration Number
- IRCT20121021011192N4
- Lead Sponsor
- Deputy of Research, Shahid Beheshti Universty of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Type 2 diabetes based on ADA (American Diabetes Association) 2017 guideline
Age more than 18 years old
Exclusion Criteria
History of confirmed hypersensitivity reaction to melatonin or any parts of formulation
eGFR less than 30 ml/min/1.73m2
Liver failure (child pugh B, C)
Pregnancy & lactation
Uncontrolled seizure & untreated major depressive disorder
Concurrent use of fluvoxamine & nifedipine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method